Literature DB >> 499225

89Strontium therapy of bone metastases of carcinoma of the prostatic gland.

H J Correns, M Mebel, K Buchali, D Schnorr, C Seidel, E Mitterlechner.   

Abstract

Following a firm diagnostic and therapeutic schedule for patients with prostatic carcinoma. 89Strontium therapy was introduced for multiple metastases. Positive skeletal scintigraphy with 99mTc-EHDP induced check for affinity to Sr using 85Sr scintigraphy. Of 80 patients, multiple metastases were found in 26. Therapy with 1 mCi of 89Sr-chloride was started in 20 cases. In 8 patients, relief from severe pain appeared shortly afterward, and a further 8 it was possible to prevent the development of pain. Moderate success in 3 cases and a failure to provide relief in 1 were observed.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 499225     DOI： 10.1007/bf00257567

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  9 in total

1.  [Concentration of 99mTc-tin-phosphate complexes in soft tissues].

Authors:  U Büll; H von Lieven; B Leisner
Journal:  Nucl Med (Stuttg)       Date:  1975-06-30

2.  [Sources of error in the interpretation of bone scans with 99mTc-diphosphonate (author's transl)].

Authors:  H Döge; B A Johansen; K Hennig
Journal:  Rofo       Date:  1977-03

3.  Multiple myeloma; a study of 24 patients treated with radioactive isotopes (P32 and SR89).

Authors:  J H LAWRENCE; L R WASSERMAN
Journal:  Ann Intern Med       Date:  1950-07       Impact factor: 25.391

4.  [Diagnosis of skeletal metastases in prostatic cancer using gamma camera (author's transl)].

Authors:  H Langhammer; R Sintermann; K Kempken; G Hör; H W Pabst; M Fendl
Journal:  Med Klin       Date:  1977-05-27

5.  [Bone scanning with 99m-Tc-polyphosphate and strontium isotopes (author's transl)].

Authors:  H Creutzig; H Hundeshagen
Journal:  Fortschr Geb Rontgenstr Nuklearmed       Date:  1973-11

6.  [Kinetics of radiostrontium].

Authors:  N Firusian
Journal:  Nucl Med (Stuttg)       Date:  1974-08-31

7.  Distribution pattern of metastatic bone disease. A need for total body skeletal image.

Authors:  G T Krishnamurthy; M Tubis; J Hiss; W H Blahd
Journal:  JAMA       Date:  1977-06-06       Impact factor: 56.272

8.  Results of 89strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report.

Authors:  N Firusian; P Mellin; C G Schmidt
Journal:  J Urol       Date:  1976-12       Impact factor: 7.450

9.  Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.

Authors:  D L Schaffer; H P Pendergrass
Journal:  Radiology       Date:  1976-11       Impact factor: 11.105
  9 in total
  3 in total

1.  Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma.

Authors:  K Buchali; H J Correns; M Schuerer; D Schnorr; H Lips; K Sydow
Journal:  Eur J Nucl Med       Date:  1988

2.  Strontium 89 for palliation of bone metastases.

Authors:  E K Reddy; R G Robinson; C M Mansfield
Journal:  J Natl Med Assoc       Date:  1986-01       Impact factor: 1.798

3.  Samarium-153 EDTMP therapy of disseminated skeletal metastasis.

Authors:  J H Turner; A A Martindale; P Sorby; E L Hetherington; R F Fleay; R F Hoffman; P G Claringbold
Journal:  Eur J Nucl Med       Date:  1989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.